Riskpilot← Back to searchSign inGet full accessMedicolle AB
ABActiveOrg 5562117894Mediavägen 14 CWholesale of pharmaceutical and medical goods · NACE 4646Est. 19812 employees
Revenue 2025
SEK 19,9M
+23% vs 2024
EBITDA margin
16.6%
+47% vs 2024
Equity ratio
25.5%
Financial strength
Net profit 2025
SEK 2,5M
+57% vs 2024
| Revenue | SEK 19,9M | +23% |
| EBITDA | SEK 3,3M | +47% |
| Net profit | SEK 2,5M | +57% |
| Total assets | SEK 20,6M | +70% |
| Equity | SEK 5,3M | +1% |
| Employees | 2 | — |
Legal name
Medicolle AB
Org number
5562117894
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
28 augusti 1981
Share capital
SEK 300 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Fransén, Karl Anders
Company purpose
Föremålet för bolagets verksamhet är fösäljning, marknadsföring och teknisk service av medicintekniska produkter, läkemedel och konsumentprodukter och därmed förenlig verksamhet.
Address
Mediavägen 14 C
Phone
+4686546615
Email
info@medicolle.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 10 906 | 18 830 | 15 753 | 16 168 | 19 925 |
| Staff expenses | — | — | — | −1 726 | −1 892 |
| EBITDA | 3 298 | 1 525 | 2 754 | 2 246 | 3 302 |
| Depreciation & amort. | −8 | −87 | −162 | −180 | −27 |
| EBIT | 3 290 | 1 438 | 2 592 | 2 066 | 3 275 |
| Net financials | −36 | −33 | −122 | −135 | −153 |
| Profit before tax | 2 634 | 1 048 | 1 953 | 2 050 | 3 211 |
| Tax | −569 | −220 | −416 | −440 | −680 |
| Net profit | 2 065 | 828 | 1 537 | 1 611 | 2 531 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 7 435 | 12 182 | 10 523 | 12 144 | 20 621 |
| Equity | 3 259 | 4 087 | 3 624 | 5 235 | 5 266 |
| Long-term debt | 609 | 725 | 673 | 0 | 1 137 |
| Short-term debt | 2 284 | 5 732 | 4 070 | 4 872 | 12 271 |
| Total debt | 2 893 | 6 457 | 4 743 | 4 872 | 13 408 |
EBITDA margin
16.6%
This company
15.8%
Market median
+5% vs market
20212025
Equity ratio
25.5%
This company
38.2%
Market median
-33% vs market
20212025
Return on equity
48.1%
This company
18.4%
Market median
+161% vs market
20212025
Net profit margin
12.7%
This company
8.1%
Market median
+57% vs market
20212025
Asset turnover
0.97×
This company
1.12×
Market median
+13% vs market
20212025
Debt / equity
2.92×
This company
0.62×
Market median
-371% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JO Chief Auditor | Chief Auditor | 2021 |
KA Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (2) | ||
JC Chief Executive Officer | Chief Executive Officer | 2021 – 2021 |
JG | Audit | 2021 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Altostratus AB
Medicolle AB Board members of Medicolle AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Olof Tilander | Chief Auditor | 0 companies |
| Jan Christer Folke Isaksson | Chief Executive Officer | 0 companies |
| Karl Anders Fransén | Chief Executive Officer | 0 companies |
| Jan Georg Emanuel Lindblad | Audit | 0 companies |
| Jan-Magnus Rune Isaksson | Deputy Board Member | 0 companies |
| Håkan Bertil Kristoffer Jarefelt | Deputy Board Member | 0 companies |